perfluorohexyloctane 眼科溶液:对干眼疾病的审查
Amy Zhuang-Yan1, Yahiya Y Syed2
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. amy.zhuang-yan@springer.com.
Drugs
|March 30, 2024
概括
perfluorohexyloctane 眼科溶液有效治疗与梅博米腺功能障碍 (MGD) 相关的干眼疾病 (DED). 这种新的治疗方法稳定了眼膜.
科学领域:
- 眼科医生 眼科 眼科
- 干眼疾病研究 干眼疾病研究
- 眼睛表面疾病 眼睛表面疾病
背景情况:
- 干眼疾病 (DED) 经常与梅博米腺功能障碍 (MGD) 相关,导致过度的眼蒸发.
- 催膜的脂质层在防止蒸发方面发挥着至关重要的作用.
研究的目的:
- 评估 perfluorohexyloctane 眼科溶液对与MGD相关的DED的疗效和耐受性.
- 评估DED患者中 perfluorohexyloctane眼科溶液的长期影响.
主要方法:
- 第三期临床试验 (GOBI和MOJAVE) 涉及患有DED和MGD的成年人.
- 与低血压盐水相比,每天每只眼睛每天四次服用一滴 perfluorohexyloctane 眼部溶液,持续 8 周,与低血压盐水相比.
- 一项扩展研究 (KALAHARI) 评估了长期结果,长达52周.
主要成果:
- 与安慰剂相比, perfluorohexyloctane 眼部溶液在DED的体征和症状中表现出了统计学上显著和临床上有意义的改善.
- 治疗一般耐受良好,大多数不良事件为轻度至中度.
- 在延长研究中,有效性和耐受性持续至52周.
结论:
- perfluorohexyloctane眼科溶液是第一类,无防腐剂的治疗与MGD相关的DED.
- 它通过稳定膜的脂质层来解决过度的眼蒸发问题.
- 它代表了一种有价值的新疗法选择,用于在美国管理DED.
相关概念视频
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...